Drug
cytarabine
2 HCP commentary reports on clinical trials studying cytarabine. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| KO-MEN-017 NCT07007312 · Kura Oncology, Inc. | Acute myeloid leukemia | Phase 3 | 34 | 7 | Focused | Oct 19, 2026 | Preview |
| CALGB-10403 NCT00558519 · Alliance for Clinical Trials in Oncology | Leukemia | Phase 2 | 1,065 | 28 | Deep | Oct 8, 2026 | Preview |